Bhanwra, S. and Ahluwalia, K. 2016. Empagliflozin: the latest SGLT2 inhibitor on the block. International Journal of Basic & Clinical Pharmacology. 5, 2 (Dec. 2016), 539–542. DOI:https://doi.org/10.18203/2319-2003.ijbcp20160777.